These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 29476201)

  • 1. Pharmacological targets of breast cancer stem cells: a review.
    Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK
    Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):463-479. PubMed ID: 29476201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
    Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
    Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarrier based approaches for targeting breast cancer stem cells.
    Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK; Karri VVSR
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):885-898. PubMed ID: 28826237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNAs in breast cancer stem cells.
    Schwarzenbacher D; Balic M; Pichler M
    Int J Mol Sci; 2013 Jul; 14(7):14712-23. PubMed ID: 23860207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
    Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Stem Cells and Sex Steroid Hormones.
    Flores-Ramírez I; Baranda-Avila N; Langley E
    Curr Stem Cell Res Ther; 2019; 14(5):398-404. PubMed ID: 30095060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
    Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
    El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors.
    Semenza GL
    Clin Sci (Lond); 2015 Dec; 129(12):1037-45. PubMed ID: 26405042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.
    Gwili N; Jones SJ; Amri WA; Carr IM; Harris S; Hogan BV; Hughes WE; Kim B; Langlands FE; Millican-Slater RA; Pramanik A; Thorne JL; Verghese ET; Wells G; Hamza M; Younis L; El Deeb NMF; Hughes TA
    Br J Cancer; 2021 Sep; 125(7):983-993. PubMed ID: 34253873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer stem cells: Multiple capacities in tumor metastasis.
    Geng SQ; Alexandrou AT; Li JJ
    Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy.
    Xiang L; Semenza GL
    Adv Cancer Res; 2019; 141():175-212. PubMed ID: 30691683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
    Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
    Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer stem cells, EMT and therapeutic targets.
    Kotiyal S; Bhattacharya S
    Biochem Biophys Res Commun; 2014 Oct; 453(1):112-6. PubMed ID: 25261721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.